Singapore markets close in 4 hours 38 minutes

Innate Pharma S.A. (0EVI.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
2.7225+0.1900 (+7.50%)
At close: 04:12PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
51,901
51,901
49,580
12,110
56,155
-
Cost of revenue
-
-
-
-
3,042
45,158
Gross profit
-
-
-
-
53,791
23,815
Operating expenses
Research development
56,022
56,022
51,663
47,004
49,708
-
Selling general and administrative
11,748
11,748
14,473
15,991
12,691
-
Total operating expenses
64,570
64,570
66,005
59,937
55,076
-
Operating income or loss
-12,669
-12,669
-16,425
-47,827
1,079
-
Interest expense
640
640
288
312
341
-
Total other income/expenses net
2,562
2,562
-41,805
2,330
-2,131
-
Income before tax
-7,570
-7,570
-57,972
-45,478
-829
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-7,570
-7,570
-57,972
-45,478
-829
-
Net income
-7,570
-7,570
-58,103
-52,809
-63,984
-
Net income available to common shareholders
-7,570
-7,570
-58,103
-52,809
-63,984
-
Basic EPS
-0.79
-0.09
-0.73
-0.66
-0.81
-
Diluted EPS
-0.79
-0.09
-0.73
-0.66
-0.81
-
Basic average shares
79,923
84,111
79,640
79,543
78,935
-
Diluted average shares
79,923
84,111
79,640
79,543
78,935
-